Janus Henderson Group plc 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:34 pm Sale | 2025-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | JANUS HENDERSON GROUP PLC JHG | 1,584,843 7.000% | -257,847 (-13.99%) | Filing |
| 2025-11-14 12:06 pm Sale | 2025-09-30 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | JANUS HENDERSON GROUP PLC JHG | 1,842,690 8.300% | -349,063 (-15.93%) | Filing |
| 2025-08-14 11:24 am Sale | 2025-06-30 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | JANUS HENDERSON GROUP PLC JHG | 2,191,753 9.900% | -14,231 (-0.65%) | Filing |
| 2025-05-14 12:15 pm Sale | 2025-03-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | JANUS HENDERSON GROUP PLC JHG | 2,205,984 10.000% | -2,410 (-0.11%) | Filing |
| 2025-02-14 12:10 pm Sale | 2024-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | JANUS HENDERSON GROUP PLC JHG | 2,208,394 10.100% | -693,656 (-23.90%) | Filing |